Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Haemonetics Corp. buy BTIG Research

Haemonetics Corp.
Start price
€72.00
09.01.26 / 50%
Target price
€75.54
09.01.27
Performance (%)
-37.78%
Price
€44.80
06.05.26
Summary
This prediction is currently active. The BUY prediction by BTIG_Research for Haemonetics Corp. is performing very badly with a performance of -37.78%. This prediction currently runs until 09.01.27. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Haemonetics Corp. -12.157% -12.157%
iShares Core DAX® 0.224% 1.487%
iShares Nasdaq 100 6.047% 16.188%
iShares Nikkei 225® 5.724% 11.690%
iShares S&P 500 2.172% 8.056%

Comments by BTIG_Research for this prediction

In the thread Haemonetics Corp. diskutieren
Prediction Buy
Perf. (%) -37.78%
Target price 75.539
Change
Ends at 09.01.27

Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.
Ratings data for HAE provided by MarketBeat

BTIG Research 
0
Report Share
09.01.26

Stopped prediction by BTIG_Research for Haemonetics Corp.

buy
Haemonetics Corp.

Start price
Target price
Perf. (%)
€48.40
06.02.26
€74.64
06.02.27
-7.44%
06.05.26

BTIG Research 
06.02.26 50%
buy
Haemonetics Corp.

Start price
Target price
Perf. (%)
€67.50
21.11.25
€76.29
21.11.26
-33.63%
06.05.26

BTIG Research 
21.11.25 50%
buy
Haemonetics Corp.

Start price
Target price
Perf. (%)
€57.50
06.11.25
€76.46
06.11.26
-22.09%
06.05.26

BTIG Research 
06.11.25 50%
buy
Haemonetics Corp.

Start price
Target price
Perf. (%)
€66.50
10.09.24
€101.52
10.09.25
-32.03%
11.09.25

BTIG Research 
10.09.24 50%